Terms: = Sarcomas AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Prognosis
4 results:
1. Specific targeting of a naturally presented osteosarcoma antigen, papillomavirus binding factor peptide, using an artificial monoclonal antibody.
Tsukahara T; Emori M; Murata K; Hirano T; Muroi N; Kyono M; Toji S; Watanabe K; Torigoe T; Kochin V; Asanuma H; Matsumiya H; Yamashita K; Himi T; Ichimiya S; Wada T; Yamashita T; Hasegawa T; Sato N
J Biol Chem; 2014 Aug; 289(32):22035-47. PubMed ID: 24962571
[TBL] [Abstract] [Full Text] [Related]
2. [A primary study of the association of human leucocyte antigen and osteosarcoma].
Zhang W; Shen C; Cai T
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):309-12. PubMed ID: 11038768
[TBL] [Abstract] [Full Text] [Related]
3. Malignant bone and soft-tissue tumor and HLA.
Wong AC
Nihon Seikeigeka Gakkai Zasshi; 1985 Jul; 59(7):719-33. PubMed ID: 3864905
[TBL] [Abstract] [Full Text] [Related]
4. Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma.
Pollack MS; Safai B; Myskowski PL; Gold JW; Pandey J; Dupont B
Tissue Antigens; 1983 Jan; 21(1):1-8. PubMed ID: 6601312
[TBL] [Abstract] [Full Text] [Related]
